Literature DB >> 33920792

Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes.

Roberta Zupo1, Fabio Castellana1, Francesco Panza1, Marco Castellana1, Luisa Lampignano1, Raffaele Ivan Cincione2, Vincenzo Triggiani3, Gianluigi Giannelli4, Vittorio Dibello5, Rodolfo Sardone1, Giovanni De Pergola1,6.   

Abstract

Screening for non-alcoholic fatty liver disease (NAFLD) is key step for primary management of fatty liver in the clinical setting. Excess weight subjects carry a greater metabolic risk even before exhibiting pathological patterns, including diabetes. We characterized the cross-sectional relationship between routine circulating biomarkers and NAFLD in a large sample of diabetes-free subjects with overweight or obesity, to elucidate any independent relationship. A population sample of 1232 consecutive subjects with a body mass index of at least 25 kg/m2, not receiving any drug or supplemental therapy, was studied. Clinical data and routine biochemistry were analyzed. NAFLD was defined using the validated fatty liver index (FLI), classifying subjects with a score ≥ 60% as at high risk. Due to extreme skewing of variables of interest, resampling matching for age and sex was performed. Our study population was characterized by a majority of females (69.90%) and a prevalence of NAFLD in males (88.90%). As a first step, propensity score matching was explicitly performed to balance the two groups according to the FLI cut-off. Based on the resulting statistical trajectories, corroborated even after data matching, we built two logistic regression models on the matched population (N = 732) to verify any independent association. We found that each unit increase of FT3 implicated a 50% increased risk of NAFLD (OR 1.506, 95%CI 1.064 to 2.131). When including glycated haemoglobin (HbA1c) in the model, free-triiodothyronine (FT3) lost significance (OR 1.557, 95%CI 0.784 to 3.089) while each unit increase in HbA1c (%) indicated a significantly greater NAFLD risk, by almost two-fold (OR 2.32, 95%CI 1.193 to 4.512). Glucose metabolism dominates a key pathway along the hazard trajectories of NAFLD, turned out to be key biomarker in monitoring the risk of fatty liver in diabetes-free overweight subjects. Each unit increase in HbA1c (%) indicated a significantly greater NAFLD risk, by almost two-fold, in our study.

Entities:  

Keywords:  glycated haemoglobin; non-alcoholic fatty liver disease; obesity

Year:  2021        PMID: 33920792     DOI: 10.3390/jcm10081695

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  2 in total

1.  A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight.

Authors:  Giovanni De Pergola; Fabio Castellana; Roberta Zupo; Sara De Nucci; Francesco Panza; Marco Castellana; Luisa Lampignano; Martina Di Chito; Vincenzo Triggiani; Rodolfo Sardone; Gianluigi Giannelli
Journal:  Sci Rep       Date:  2021-12-16       Impact factor: 4.379

2.  Associations between serum biomarkers and non-alcoholic liver disease: Results of a clinical study of Mediterranean patients with obesity.

Authors:  Sara De Nucci; Fabio Castellana; Roberta Zupo; Luisa Lampignano; Martina Di Chito; Roberta Rinaldi; Vito Giannuzzi; Raffaele Cozzolongo; Giuseppina Piazzolla; Gianluigi Giannelli; Rodolfo Sardone; Giovanni De Pergola
Journal:  Front Nutr       Date:  2022-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.